Explore the details: https://bit.ly/4elSxHq
A trial will test whether noninvasive nerve stimulation paired with hand rehab can improve function and support myelin repair in MS.

Explore the details: https://bit.ly/4elSxHq
A trial will test whether noninvasive nerve stimulation paired with hand rehab can improve function and support myelin repair in MS.
Get the scoop: https://bit.ly/4yJn4qY
Scientists have engineered a human "mini-brain" model that mimics MS damage and repair, offering a new way to test myelin-repairing therapies.
Discover more: https://bit.ly/3TtM9Hf
Quantum is working with Thermo Fisher to prepare a Phase 2 trial of Lucid-MS in progressive MS after FDA clearance.
Get the scoop: https://bit.ly/3TLgQrd
Columnist Desiree Lama looks forward to the change in seasons this autumn as a chance to listen to her body a little more closely.
Take a closer look: https://bit.ly/4yrR3Tz
A personalized neuropsychological rehab program may help people with MS manage cognitive issues, according to a feasibility study.
Get the scoop: https://bit.ly/4ycaYWn
Higher physical activity was linked to lower MS risk mainly among people with low sun exposure in a Swedish study.
Discover more: https://bit.ly/4hLFwb8
Adding probiotics to standard MS therapies may help to reduce fatigue, depression, and disability levels in RRMS, per data from a small trial.
Get the scoop: https://bit.ly/4dp6NyQ
The National MS Society launched a 'Campaign to End MS,' aiming to raise $1 billion for research and to improve access to care and support.
Discover more: https://bit.ly/4zlggzP
A fast-track diagnostic pathway that includes a specific MRI marker helped cut the average time to diagnose MS by about half, per a review.
Get the scoop: https://bit.ly/4jAlJxU
A study tied altered neurovascular coupling, which matches brain activity with blood flow, to poorer cognitive function in MS.
Take a closer look: https://bit.ly/4iZNzUa
The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved for two MS types.
Get the scoop: https://bit.ly/4yqdlpj
An estimated 3.1 million people worldwide are now living with MS, up from about 2.8 million in 2020 and 1.8 million in 2013, a report shows.
Get the scoop: https://bit.ly/4hlq3jd
Having MS results in columnist Desiree Lama waging a sometimes silent battle against pain, but she's learning to listen to her body's cues.
Take a closer look: https://bit.ly/4rCpkgW
Experimental therapy kamuvudine-9 (K-9), derived from antiviral drugs, restored lost mobility and vision in a preclinical MS study.
Take a closer look: https://bit.ly/4z2i3tf
A digital lifestyle program was linked to lasting improvements in several measures reported by multiple sclerosis patients, a study says.
Discover more: https://bit.ly/3VnJC1G
A study found 55 DNA methylation regions differed in pediatric MS, with Epstein-Barr virus infection emerging as the top-ranked pathway.
Take a closer look: https://bit.ly/3Tx5ZBg
Higher blood levels of a marker of nerve damage are associated with lower daily activity in people with progressive forms of MS, per a study.
Discover more: https://bit.ly/4hpyxo1
Since her MS diagnosis in 2012, guest columnist Shereese Hickson has learned that thriving with the condition means redefining strength.
Get the scoop: https://bit.ly/4yXZ8Qb
A high-fat diet alters the composition of gut bacteria in multiple sclerosis, which may ultimately lead to brain damage, per a mouse study.
Take a closer look: https://bit.ly/4yN1nWs
A new study confirms that EBV infection increases thew risk of MS and shows that common herpesviruses have differing roles in the disease.